title: 3 dimensional cell cultures: a comparison between manually and automatically produced alginate beads.
abstract: Cancer diseases are a common problem of the population caused by age and increased harmful environmental influences. Herein, new therapeutic strategies and compound screenings are necessary. The regular 2D cultivation has to be replaced by three dimensional cell culturing (3D) for better simulation of in vivo conditions. The 3D cultivation with alginate matrix is an appropriate method for encapsulate cells to form cancer constructs. The automated manufacturing of alginate beads might be an ultimate method for large-scaled manufacturing constructs similar to cancer tissue. The aim of this study was the integration of full automated systems for the production, cultivation and screening of 3D cell cultures. We compared the automated methods with the regular manual processes. Furthermore, we investigated the influence of antibiotics on these 3D cell culture systems. The alginate beads were formed by automated and manual procedures. The automated steps were processes by the Biomek(®) Cell Workstation (celisca, Rostock, Germany). The proliferation and toxicity were manually and automatically evaluated at day 14 and 35 of cultivation. The results visualized an accumulation and expansion of cell aggregates over the period of incubation. However, the proliferation and toxicity were faintly and partly significantly decreased on day 35 compared to day 14. The comparison of the manual and automated methods displayed similar results. We conclude that the manual production process could be replaced by the automation. Using automation, 3D cell cultures can be produced in industrial scale and improve the drug development and screening to treat serious illnesses like cancer.
authors.affiliation: Center for Life Science Automation (celisca), University of Rostock, Friedrich-Barnewitz Str. 8, 18119, Rostock, Germany. ricarda.lehmann@celisca.de.
authors.forename: R
authors.initials: R
authors.lastname: Lehmann
authors.affiliation: Center for Life Science Automation (celisca), University of Rostock, Friedrich-Barnewitz Str. 8, 18119, Rostock, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Gallert
authors.affiliation: Center for Life Science Automation (celisca), University of Rostock, Friedrich-Barnewitz Str. 8, 18119, Rostock, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Roddelkopf
authors.affiliation: Institute of Automation, University Rostock, Rostock, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Junginger
authors.affiliation: Institute of Anatomy, University Rostock, Rostock, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Wree
authors.affiliation: Center for Life Science Automation (celisca), University of Rostock, Friedrich-Barnewitz Str. 8, 18119, Rostock, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Thurow
keywords: 3-D cell culturing; Alginate beads; Alginate matrix; Automated cell culturing; Cancer; Cervix carcinoma cells; Life science automation (LSA)
references.citation: Nature. 2003 Feb 6;421(6923):661, 663, 665-6
references.pmid: 12571603
references.citation: Nat Methods. 2007 Oct;4(10):855-60
references.pmid: 17767164
references.citation: Cancer Sci. 2012 Jul;103(7):1230-7
references.pmid: 22435758
references.citation: Artif Organs. 2009 Dec;33(12):1117-26
references.pmid: 20078562
references.citation: Cytotechnology. 1995 Jun;19(2):95-105
references.pmid: 22359010
references.citation: Nat Methods. 2008 Jan;5(1):109-12
references.pmid: 18165807
references.citation: J Mater Sci Mater Med. 2011 Sep;22(9):2089-95
references.pmid: 21744104
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):399-404
references.pmid: 19126683
references.citation: Tissue Eng. 2006 Jul;12(7):2025-30
references.pmid: 16889530
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Antimicrob Agents Chemother. 2007 Jan;51(1):54-63
references.pmid: 17088489
references.citation: Biotechnol Bioeng. 2013 Dec;110(12):3258-68
references.pmid: 23801027
references.citation: Cancer Treat Rev. 2013 Aug;39(5):430-43
references.pmid: 22727690
references.citation: Biofabrication. 2009 Jun;1(2):022001
references.pmid: 20811099
references.citation: J Biomed Mater Res A. 2013 Nov;101(11):3285-94
references.pmid: 23983201
references.citation: Cytotechnology. 2008 Sep;58(1):49-56
references.pmid: 19002776
references.citation: Toxicol Lett. 2002 Feb 28;127(1-3):153-60
references.pmid: 12052653
references.citation: Biomaterials. 2011 Feb;32(6):1477-83
references.pmid: 21095000
references.citation: Exp Cell Res. 2013 Aug 15;319(14):2135-44
references.pmid: 23707395
references.citation: Nat Rev Mol Cell Biol. 2007 Oct;8(10):839-45
references.pmid: 17684528
references.citation: Stem Cell Res. 2013 Nov;11(3):978-89
references.pmid: 23900167
references.citation: Methods Cell Biol. 1998;57:49-65
references.pmid: 9648099
references.citation: Acta Biomater. 2013 Dec;9(12):9343-50
references.pmid: 23891740
references.citation: Connect Tissue Res. 2011;52(6):503-11
references.pmid: 21787134
references.citation: Curr Opin Biotechnol. 2012 Oct;23(5):803-9
references.pmid: 22326911
references.citation: Nucleic Acids Res. 2005 Oct 07;33(17):5677-90
references.pmid: 16214802
references.citation: Oncogene. 2003 Sep 29;22(42):6524-36
references.pmid: 14528277
references.citation: Clin Chem. 2000 May;46(5):764-71
references.pmid: 10794775
references.citation: Integr Biol (Camb). 2010 Oct;2(10):517-27
references.pmid: 20820630
references.citation: Tissue Eng. 2007 Sep;13(9):2153-62
references.pmid: 17516855
references.citation: Rev Infect Dis. 1979 May-Jun;1(3):434-67
references.pmid: 45147
references.citation: J Tissue Eng Regen Med. 2010 Jan;4(1):45-54
references.pmid: 19842115